Victoria Klepsch

Medizinische Universität Innsbruck

H-index: 12

Europe-Austria

About Victoria Klepsch

Victoria Klepsch, With an exceptional h-index of 12 and a recent h-index of 12 (since 2020), a distinguished researcher at Medizinische Universität Innsbruck, specializes in the field of tumor immunology, T cell signaling, nuclear receptors, immune checkpoint therapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Melanoma-intrinsic NR2F6 activity regulates antitumor immunity

A MLR-Based Approach to Analyze Regulators of T Lymphocyte Activation In Vivo

Emerging next-generation target for cancer immunotherapy research: the orphan nuclear receptor NR2F6

Loss of the orphan nuclear receptor NR2F6 enhances CD8+ T-cell memory via IFN-γ

Iron supplementation interferes with immune therapy of murine mammary carcinoma by inhibiting anti-tumor T cell function

Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy

A new target in T cells primes the body for immune checkpoint therapy

Victoria Klepsch Information

University	Medizinische Universität Innsbruck
Position	Translational Cell Genetics
Citations(all)	965
Citations(since 2020)	855
Cited By	409
hIndex(all)	12
hIndex(since 2020)	12
i10Index(all)	17
i10Index(since 2020)	16
Email	Access Email
University Profile Page	Medizinische Universität Innsbruck
Google Scholar	View Google Scholar Profile